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Abstract  
Objective To compare the efficacy of azithromycin plus levamisole versus azithromycin alone in the treatment of 
moderate to severe acne. 
Patients and methods Ninety patients with moderate to severe acne were divided into two groups. Group A was 
given oral azithromycin 500mg/day, three days a week, plus oral levamisole 150mg/day, two days a week and 
group B was given oral azithromycin 500mg/day, three days a week. Patients were followed up at 4th and 8th 
week for efficacy and tolerability. 
Results Efficacy of treatment in Group A (given azithromycin plus levamisole) was seen in 36 (80%) patients 
while in Group B (oral azithromycin alone) efficacy was seen in 27 (60%) patients (p-value = 0.048).  
Conclusion Combination therapy with oral azithromycin plus levamisole is more efficacious as compared to oral 
azithromycin alone in the treatment of moderate to severe acne vulgaris. 
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Introduction 
Acne vulgaris is a common inflammatory disease of the follicular portion of the  
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pilosebaceous units.1 It is characterized by seborrhea, the formation of open and closed comedones, 
erythematous papules and pustules and in more severe cases nodules, deep pustules and pseudocysts.2 It is a 
common dermatological disease affecting almost 80% of adolescents, 4% of adult men and 13% of women.3  
      The precise mechanisms of acne are not known but there are four major pathogenic factors: 
1. Increased sebum production 
2. Hypercornification of pilosebaceous duct 
3. Abnormal bacterial function 
4. Production of inflammation  
      In addition multiple genetic and environmental factors as well as neuropeptides play a role, with 
inflammation serving as a central nidus. Propionibacterium acnes (P.acnes) has a strong pro-inflammatory 
activity and targets molecules involved in innate cutaneous immunity, keratinocytes and sebaceous glands of the 
pilosebaceous follicles.4 The microorganisms residing on the skin surface are attracted to lipid rich optimal 
environment inside the hair follicles. Here, the bacteria rapidly multiply inducing a local inflammatory response 
by releasing chemotactic substances and attracting polymorphonuclear leukocytes to the site of inflammation.5 
The innate immune system recognizes P. acnes via toll-like receptor 2 leading to secretion of inflammatory 
cytokines.6 The adaptive immune response also has a central role in inflammation.6 
      Treatment of acne depends on the type and severity of disease and includes topical and oral medications. 
Topical compounds are retinoids, benzoyl peroxide and antibiotics while antibiotics, isotretinoin and cyproterone 
acetate are commonly used oral compounds.7 Halting the inflammatory cascade by either the antibiotics or 
immune-modulating agents should offer promise in the treatment of acne meanwhile reducing the sequels of 
disease. Azithromycin is an oral antibiotic and levamisole is an immune-modulating agent, both of which act to 
surcease inflammation. Side effects of azithromycin include nausea, pain abdomen, diarrhea, vomiting and drug 
fever while use of levamisole is associated with milder gastrointestinal side effects of nausea and diarrhea and 
serious central nervous system side effects and allergic reactions are very rare.8  
     Limited data are available regarding clinical features, consequences and response of acne vulgaris to the 
therapy in Asian skin types. The present study aimed to compare the efficacy of azithromycin plus levamisole 
with azithromycin alone in the treatment of moderate to severe acne. 
 
Materials and methods   
      The study was conducted at Dermatology Department, Nishtar Hospital, Multan. Total duration of study was 
six months (from 11th October 2015 to 10th April 2016). A total of 90 patients of 18 to 35 year age group of both 
genders having moderate to severe acne with a global acne score of 19 to 38 for less than 3 months duration were 
included. Pregnant and lactating females, patients already taking anti acne therapy for last one month or more, 
those with drug induced acne and those with deranged liver function tests (LFTs) and renal function tests (RFTs) 
were excluded. Global acne grading system (GAGS) is a quantitative scoring system in which the total severity 
score is derived from summation of six regional sub-scores [Figure 1]. 
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Written informed consent was taken prior to enrollment of patients. They were randomly allocated into two 
study groups, A and B, by lottery method, with forty five patients in each group. Group A was given oral 
azithromycin 500 mg/day, three days a week, plus oral levamisole 150 mg/day, two days a week.8 Group B, also 
having 45 patients was given oral azithromycin 500 mg/day, three days a week.8  Patients were followed up on 
every 4th week and side effects were noted. On 8th week of treatment efficacy was assessed. 
 
Figure 1 The Global acne grading system 
 
      Efficacy of both the treatments was assessed by calculating pre and post treatment global acne score. More 
than or equal to 50% reduction of global acne score from baseline was labeled as efficacious response whereas 
with less than 50% reduction of global acne score from baseline treatment was labeled as non-efficacious. 
 
 Results 
      Of 90 patients, 62 (68.89%) were females and 28 (31.11%) were males with female to male ratio of 2.5:1. 
Mean age of patients in group A was 27.93 ± 4.7 years and in group B it was 27.8 ± 4.72 years. Mean weight of 
patients in group A was 74.13 ± 7.8 kg and in group B it was 72.7 ± 8.1 kg. Mean duration of disease in group A 
was 6.24 ± 3.2 weeks and in group B it was 6.53 ± 3.34 weeks. Mean Body Mass Index (BMI) of patients in 
group A was 27.7 ± 3.69 kg/m2 and in group B it was 27.2 ± 3.92 kg/m2 [Table 1]. Efficacy of treatment in 
Group A (given azithromycin plus levamisole) was seen in 36 (80%) patients while in Group B (oral 
azithromycin alone) efficacy was seen in 27 (60%) patients (P value = 0.048) [Figure 3]. No serious side effects 
were noted in both groups. A very few people of either group reported nausea and diarrhea which resolved on its 
own with the continuation of treatment. 
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Table 1 Mean age, weight, disease duration, BMI of patients, gender and global acne scores of patients 
undergoing treatment 
Variables  Group A Group B 
Mean age (years) 27.93 ± 4.7 27.8 ± 4.72 
Gender 
          Male 
          Female 
 
15 (33.3%) 
30 (66.6%) 
 
13 (28.9%) 
32 (71.1%) 
Mean weight of patients (kg) 74.13 ± 7.8 72.7 ± 8.1 
Mean duration of disease (weeks) 6.24 ± 3.2 6.53 ± 3.34 
Mean BMI of patients (kg/m2) 27.7 ± 3.69 27.2 ± 3.92 
Global acne scores 
      Moderate acne (score 18-30) 
      Severe acne (score 31-38) 
 
29 
16 
 
31 
14 
 
       Acne, a very common disease of adulthood and as it affects the face, the lesions of acne cause much 
cosmetic concern and psychological distress. It was originally thought that the lesions developed after abnormal 
exfoliation of the keratinocytes lining the sebaceous follicles, leading to hypercornification and development of a  
microcomedone. However, as the research and technology advanced, there has been a  paradigm shift with 
regard to understanding the pathogenesis of acne which is now viewed as a primary inflammatory skin disorder.9 
Current data suggests that P. acnes plays a central role in inflammation.  P. acnes is a gram-positive anaerobic 
bacteria that is normally found in the sebaceous follicle. Increased numbers of P. acnes are commonly found in 
the follicles of acne patients and reduction in these counts correlates with clinical improvement in acne patients. 
Accordingly, antimicrobial agents and antibiotics have been a mainstay of acne therapy targeting P. acnes 
colonies. Antibiotic resistance to P. acnes is increasing10 due to various factors, such as biofilm production by P. 
acnes and the inability of P. acnes to be killed or ingested by neutrophils and macrophages.  The biofilm 
excreted by P. acnes is a glycocalyx polymer and may contribute to its persistence and immunogenicity.11 P. 
acnes releases various cytokines which modulate T-helper cell 1/T-helper cell 2 (Th1/Th2) responses in acne 
patients. The role of oral antibiotics in acne is mainly by addressing the colonization of P. acnes while adding 
levamisole will therefore increase the efficacy by regulating immune system. 
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Figure 2 Improvement in acne at the end of 8 week treatment with azithromycin plus levamisole 
 
 
Figure 3 Comparison of percentages of patients improved after treatment in both groups 
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Discussion 
      A research carried out in the dermatology clinic of Rasoul-e-Akram Hospital in Tehran, Iran in 2006 
demonstrated that combination treatment with doxycycline and levamisole yielded greater reduction in lesion 
count than doxycycline alone so it was concluded that when used as an adjuvant with other drug such as oral 
antibiotics, levamisole acting synergistically is an effective treatment for severe non-responsive acne vulgaris.12 
A study conducted at Ahvaz Jundishapur University of Medical Sciences in Iran in 2011 has demonstrated 
that combination of azithromycin and levamisole resulted in 76.93% and 82.35% reduction of papules, pustules 
and nodulocystic lesions vs 69.32% and 57.99% with azithromycin alone. These two studies showed better 
response with levamisole as an adjuvant to antibiotics compared to antibiotics alone. 
      Our study compared azithromycin plus levamisole with azithromycin alone in the treatment of moderate to 
severe acne patients. It was seen that those who received combination of azithromycin and levamisole showed 
80% response and those who were given azithromycin alone showed 60% response. The effectiveness of both 
groups was compared using chi-square test and P value was found to be 0.048 showing that there is a significant 
difference (P value ≤ 0.05) in the efficacy of both groups. 
 
Conclusion 
      Our study concluded that azithromycin plus levamisole combination therapy is more efficacious as compared 
to azithromycin alone in the treatment of moderate to severe acne vulgaris. So, this combination therapy of 
azithromycin and levamisole can be opted as a better treatment modality as this regime makes the treatment 
more acceptable, cost effective, with an acceptable safety profile because of lower incidence of dose related side 
effects. 
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